HEAL WELL. AGE WELL. LIVE LONGER.(800) 266-7207   ·   contact@clearhealthpass.com
Industry perspective

“Regulated” and “approved” are different words.

FDA’s tissue-product explainer helps readers understand the regulatory vocabulary around HCT/Ps.

Illustrative image for Regenerative medicine
U.S. Food & Drug Administration / Resource checked November 6, 2026

FDA explains how human cells and tissue products are regulated. Products that meet the criteria for regulation solely under Section 361 follow a different framework from products requiring approval or licensure. The distinction matters when reading a company website or evaluating a treatment claim.

A question to take with you.

Which exact regulatory category applies to the product, and what does that category establish?

Read the primary source ↗

An editorial summary, not independent medical or investment advice. External source content is not a statement of CHP’s operational status.

Back to news & perspectives↗